AILEENS PHARMA
The company intends to use the funds to accelerate the development of its platform of topical non-steroidal treatments for atopic dermatitis both in children and adults, as well as other types of dermatological disorders.
AILEENS PHARMA
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2018-06-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.aileenspharma.com
Total Employee:
1+
Status:
Active
Total Funding:
3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Apache
Similar Organizations
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Panakes Partners
Panakes Partners investment in Series A - Aileens Pharma
Official Site Inspections
http://www.aileenspharma.com
- Host name: lhcp2028.webapps.net
- IP address: 185.2.5.28
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Aileens Pharma" on Search Engine
Aileens Pharma | Ride the Future
Designed by shishi. Our mission is to provide the first non-pharmacological topic treatment.See details»
About | Aileens Pharma
Aileens Pharma, founded in June 2018, is an Italian biotech company that develops topical non-pharmacological and non-steroidal treatment for skin diseases. Our MISSION is to provide the first safe and effective topical treatment for skin diseases that does not cause the common side effects of medications that are currently available on the market.See details»
Aileens Pharma
Designed by shishi. Our mission is to provide the first non-pharmacological topic treatment.See details»
Aileens Pharma - Crunchbase Company Profile & Funding
The company intends to use the funds to accelerate the development of its platform of topical non-steroidal treatments for atopic dermatitis both in children and adults, as well as other types of dermatological disorders.See details»
Mission | Aileens Pharma
The HA c-40 device involves the use of a non-pathogenic bacterial fragment (cellular wall), at times naturally present on human skin, which is then chemically conjugated with mucopolysaccharides acting as carriers.See details»
Aileens Pharma Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Aileens Pharma. Use the PitchBook Platform to explore the full profile.See details»
Aileens Pharma | LinkedIn
Aileens Pharma is an Italian biotech company founded in June 2018 which is developing topical non pharmacological and non steroidal treatment for dermatological diseases. Our MISSION is to...See details»
Aileens Pharma - Funding, Financials, Valuation & Investors
Aileens Pharma is adeveloper of treatments to improve clinical outcomes in patients suffering from dermatological diseases.See details»
Aileens Pharma Company Profile - Craft
Aileens Pharma is a biotech company developing a non-pharmacological and non-steroidal treatment for dermatological diseases. It offers LimpiAD, a medical device involving the use of non-pathogenic bacteria.See details»
Aileens Pharma - Crunchbase
Aileens Pharma is adeveloper of treatments to improve clinical outcomes in patients suffering from dermatological diseases.See details»
Meeting with the Founder & Ceo Of Aileens Pharma - LinkedIn
Feb 12, 2019 Sonia Longo Sormani is the executive founder and CEO of the Italian based pharmaceutical company, Aileens Pharma. The company, known for its medical supplies and services was founded in 2018,...See details»
Portfolio CDP Venture Capital | Aileens Pharma
The ecosystem supporting innovation in Italy. Aileens Pharma is a start up directly invested by CDP Venture Capital through Italy Venture I Fund.See details»
Aileens Pharma | VentureRadar
Aileens Pharma is an Italian biotech company founded in June 2018 which is developing topical non pharmacological and non steroidal treatment for dermatological diseases. Our mission is to provide the first Topical treatment with high safety and efficacy profile without the side effects of current pharmacological therapies.See details»
AILEENS PHARMA SRL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AILEENS PHARMA SRL of NOVA MILANESE, MONZA E BRIANZA. Get the latest business insights from Dun & Bradstreet.See details»
Aileens Pharma - Products, Competitors, Financials, Employees ...
Aileens Pharma is a biotech company focused on developing non-pharmacological treatments for dermatological diseases. The company specializes in creating topical treatments aimed at managing skin conditions such as atopic dermatitis without the side effects associated with pharmacological therapies.See details»
Clinical Data | Aileens Pharma
Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases. 1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of S. aureus colonization and secondary infections. 2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged 4 and …See details»
Ailees Pharma | EU-Startups
Aileens Pharma is an Italian biotech company that develops topical non-pharmacological and non-steroidal treatment for skin diseases. The company intends to use the funds to accelerate the development of its platform of topical non-steroidal treatments for atopic dermatitis both in children and adults, as well as other types of dermatological ...See details»
Supreme Court rejects controversial Purdue Pharma bankruptcy …
3 days ago Josh Reynolds/AP. The U.S. Supreme Court on Thursday invalidated a controversial bankruptcy deal involving Purdue Pharma, maker of the highly addictive painkiller Oxycontin, and members of the ...See details»
Synthesis of 3-sulfonylisoindolin-1-ones from olefinic amides and ...
Sulfonyl groups are widely found motifs in biologically active compounds and drug molecules, many isolated natural products as well as pharmaceuticals contain sulfonyl groups. Herein, we present the synthesis of sulfonyl-substituted isoindolones by electrochemical oxidative radical cascade cycloaddition reaction of olefinic amides with …See details»
Supreme Court blocks opioid settlement with Purdue Pharma that …
22 hours ago Justices tossed out a bankruptcy deal valued at more than $7 billion involving Purdue Pharma - maker of OxyContin - and the company's owners - members of the Sackler family.See details»